Takhzyro

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Takhzyro treats patients 12 years of age and older with type I and II hereditary angioedema (HAE). Takhzyro is injected under the skin (subcutaneously) every 2 weeks.

Takhzyro Overview

Reviewed: September 17, 2018
Updated: 

Takhzyro is a prescription medication used to prevent attacks of Hereditary Angioedema (HAE) in people 12 years of age and older. 

Takhzyro belongs to a group of drugs called therapeutic antibodies. It works by targeting a substance in the body known as kallikrein, which is overactive in people with HAE. By targeting kallikrein, bradykinin release is controlled, bringing levels closer to normal to prevent HAE attacks.

This medication comes in a single-dose vial as a ready-to-use solution. It is given every 2 weeks as an injection under your skin (subcutaneous) by you or a caregiver.

Common side effects include injection site reactions (like pain, bruising, redness, and rash), upper respiratory infections, and headache.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Takhzyro Drug Class

Back to Top

Takhzyro is part of the drug class: